Grifols sCD38
Managing blood delivery to oncology patients on monoclonal antibody therapies can be challenging for your lab. You can create a clearer clinical picture without lengthy procedures using Grifols soluble recombinant protein technology that blocks therapeutic monoclonal antibodies that cause pan-agglutination.